ADMA Biologics, Inc.
ADMA
$15.57
$0.040.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.22M | 26.90M | 111.90M | 35.91M | 32.06M |
| Total Depreciation and Amortization | 2.06M | 1.97M | 1.94M | 1.94M | 2.05M |
| Total Amortization of Deferred Charges | 160.00K | 190.00K | 219.00K | 252.00K | 227.00K |
| Total Other Non-Cash Items | 7.71M | 8.01M | -77.57M | 3.15M | 2.83M |
| Change in Net Operating Assets | -23.00M | -56.75M | 13.72M | -16.22M | 8.48M |
| Cash from Operations | 21.14M | -19.68M | 50.22M | 25.03M | 45.65M |
| Capital Expenditure | -2.42M | -4.70M | -2.76M | -1.06M | -2.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -105.00K | -19.00K | 7.00K | -42.00K | -299.00K |
| Cash from Investing | -2.53M | -4.72M | -2.75M | -1.10M | -2.37M |
| Total Debt Issued | 30.00M | -- | -- | -- | -- |
| Total Debt Repaid | -30.00M | -- | -30.00M | -30.00M | -- |
| Issuance of Common Stock | 2.06M | 101.00K | 443.00K | 5.69M | 331.00K |
| Repurchase of Common Stock | -1.19M | -7.23M | -644.00K | -1.16M | -693.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -825.00K | -- | -825.00K | -- | -- |
| Cash from Financing | 48.00K | -7.13M | -31.03M | -25.47M | -362.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.66M | -31.52M | 16.44M | -1.54M | 42.92M |